Carlsmed (CARL) Invested Capital (2025 - 2026)

Carlsmed (CARL) posted Invested Capital of $15.6 million for Q1 2026, little changed on a QoQ basis from $15.6 million in Q4 2025.

Carlsmed (CARL) Invested Capital (2025 - 2026) Analysis & Trends

Carlsmed's Invested Capital history runs 2 years deep, the most recent figure standing at $15.6 million for Q1 2026.

Quarterly Invested Capital changed N/A year-over-year to $15.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $62.5 million (changed N/A YoY) and the FY2025 annual result came in at $15.6 million, changed N/A from the prior year.
Invested Capital was $15.6 million for Q1 2026 at Carlsmed, roughly flat from $15.6 million in the prior quarter.
Across five years, Invested Capital topped out at $15.6 million in Q2 2025 and bottomed at $15.6 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Veeva Systems	29.34 Bn	22.03 Bn	662.02 Mn	-
2	BrightSpring Health Services	13.49 Bn	12.59 Bn	482.22 Mn	52.96 Mn
3	Healthequity	7.96 Bn	7.70 Bn	256.31 Mn	-
4	10x Genomics	6.17 Bn	5.63 Bn	106.18 Mn	-
5	Hinge Health	6.02 Bn	5.70 Bn	154.23 Mn	-
6	MiniMed	4.19 Bn	3.89 Bn	480.00 Mn	-
7	Waystar Holding	4.14 Bn	4.07 Bn	216.84 Mn	14.19 Mn
8	Doximity	3.82 Bn	3.08 Bn	125.97 Mn	-
9	Privia Health	3.10 Bn	2.73 Bn	-	-
10	Carlsmed	295.19 Mn	222.08 Mn	12.43 Mn	15.63 Mn

Download Data